Detalhe da pesquisa
1.
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.
Nat Immunol
; 21(10): 1205-1218, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839608
2.
Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.
Nat Immunol
; 25(5): 925-926, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514890
3.
Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.
Nat Immunol
; 25(4): 716, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360937
4.
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
Nat Immunol
; 18(9): 1004-1015, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28759001
5.
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.
Immunity
; 47(4): 789-802.e9, 2017 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045907
6.
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy).
J Transl Med
; 19(1): 278, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193182
7.
TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma.
Blood
; 132(16): 1689-1694, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29986909
8.
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux.
Semin Cancer Biol
; 48: 91-103, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28467889
9.
De-novo and acquired resistance to immune checkpoint targeting.
Lancet Oncol
; 18(12): e731-e741, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29208439
10.
Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects.
Blood
; 126(13): 1609-20, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26206951
11.
A balance of interleukin-12 and -23 in cancer.
Trends Immunol
; 34(11): 548-55, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23954142
12.
Supernatural T cells: genetic modification of T cells for cancer therapy.
Nat Rev Immunol
; 5(12): 928-40, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322746
13.
Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.
Mol Ther
; 22(1): 18-27, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24048441
14.
Both IFN-γ and IL-17 are required for the development of severe autoimmune gastritis.
Eur J Immunol
; 42(10): 2574-83, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22777705
15.
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis.
Proc Natl Acad Sci U S A
; 107(18): 8328-33, 2010 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20404142
16.
Biology and clinical observations of regulatory T cells in cancer immunology.
Curr Top Microbiol Immunol
; 344: 61-95, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20512555
17.
Combination therapy of established tumors by antibodies targeting immune activating and suppressing molecules.
J Immunol
; 184(10): 5493-501, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20400706
18.
ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis.
JHEP Rep
; 4(1): 100386, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34917911
19.
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors.
Sci Transl Med
; 14(642): eabj9779, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476594
20.
CD1d-based combination therapy eradicates established tumors in mice.
J Immunol
; 183(3): 1911-20, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19620318